| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0002-7575-01 | 0002-7575 | HUMAN PRESCRIPTION DRUG | Omvoh | mirikizumab-mrkz | INJECTION, SOLUTION | INTRAVENOUS | 20231026 | N/A | BLA | BLA761279 | Eli Lilly and Company | MIRIKIZUMAB | 20 mg/mL | 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-7575-01) / 15 mL in 1 VIAL, SINGLE-DOSE |
| 0002-8011-27 | 0002-8011 | HUMAN PRESCRIPTION DRUG | Omvoh | mirikizumab-mrkz | INJECTION, SOLUTION | SUBCUTANEOUS | 20231026 | N/A | BLA | BLA761279 | Eli Lilly and Company | MIRIKIZUMAB | 100 mg/mL | 2 SYRINGE in 1 CARTON (0002-8011-27) / 1 mL in 1 SYRINGE (0002-8011-01) |
| 0002-8870-27 | 0002-8870 | HUMAN PRESCRIPTION DRUG | Omvoh | mirikizumab-mrkz | INJECTION, SOLUTION | SUBCUTANEOUS | 20240429 | N/A | BLA | BLA761279 | Eli Lilly and Company | MIRIKIZUMAB | 100 mg/mL | 2 SYRINGE in 1 CARTON (0002-8870-27) / 1 mL in 1 SYRINGE (0002-8870-01) |